Europe Market Insight : In Europe, there is an increasing interest in metabolic health and weight management, with GLP-1 boosters gaining popularity for their potential to support insulin sensitivity
The smart scale is unique in our lineup and tracks lean mass, which matters because women and older adults on semaglutide face higher muscle-loss risk per ENDO 2025
Specifically, glucagon-like peptide 1 receptor agonists (arGLP-1), such as semaglutide, have demonstrated a mean weight loss approaching the 15% threshold [18,19,20]
Current Treatments for ASUDs There is a range of treatments for ASUDs, including behavioral treatments (eg, brief interventions, contingency management, motivational interviewing, motivational enhancement therapy, cognitive behavioral therapy), as well as pharmacological treatments
Understanding transition protocols helps ensure smooth changeovers
These patches claim to use a slow-release transdermal technology that delivers the drug into your bloodstream through the skin, gradually